首页 > 最新文献

American journal of clinical pathology最新文献

英文 中文
The American Society for Clinical Pathology 2024 Vacancy Survey of medical laboratories in the United States. 美国临床病理学会2024年美国医学实验室空缺调查。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf101
Edna Garcia, Jenny Diaz, Iman Kundu, Melissa Kelly, Ryan Soles

Objective: We sought to determine the extent and distribution of workforce shortages within US medical laboratories.

Methods: The survey was conducted through collaboration between the American Society for Clinical Pathology's (ASCP's) Institute for Science, Technology and Policy in Washington, DC, and the Evaluation, Measurement and Assessment Department and ASCP Board of Certification in Chicago, Illinois. Data were collected using an internet survey distributed to individuals in a position to report on staffing and certifications for their laboratories.

Results: Findings from the ASCP 2024 Vacancy Survey indicate that although vacancy rates have declined compared with 2022, they remain elevated relative to those observed before the COVID-19 pandemic. Retirement rates continue to rise, with 10 of the 17 laboratory departments surveyed reporting increases. Among surveyed laboratory departments, the most frequently cited concern regarding artificial intelligence was the challenge of adapting to emerging technologies. Despite this sentiment, the perceived potential of artificial intelligence to transform laboratory operations remains a major source of enthusiasm.

Conclusions: Current vacancy survey data suggest continued challenges in recruitment of laboratory professionals. Qualitative analysis results show that there is an urgent need for advocacy for laboratory professionals, increased credentialing of laboratory professionals, and an increase in the number of laboratory education and training programs.

目的:我们试图确定美国医学实验室劳动力短缺的程度和分布。方法:该调查由位于华盛顿特区的美国临床病理学会(ASCP)科学、技术与政策研究所与位于伊利诺伊州芝加哥市的评估、测量与评估部和ASCP认证委员会合作进行。数据是通过互联网调查收集的,这些调查分发给有能力报告其实验室人员配备和认证情况的个人。结果:ASCP 2024年空置率调查结果显示,尽管与2022年相比,空置率有所下降,但与COVID-19大流行之前相比,空置率仍然较高。退休率继续上升,在接受调查的17个实验室部门中,有10个报告退休率上升。在接受调查的实验室部门中,最常提到的关于人工智能的担忧是适应新兴技术的挑战。尽管存在这种情绪,但人们对人工智能改变实验室操作的感知潜力仍然是热情的主要来源。结论:目前的空缺调查数据表明,实验室专业人员的招聘仍面临挑战。定性分析结果表明,迫切需要宣传实验室专业人员,增加实验室专业人员的资格认证,增加实验室教育和培训计划的数量。
{"title":"The American Society for Clinical Pathology 2024 Vacancy Survey of medical laboratories in the United States.","authors":"Edna Garcia, Jenny Diaz, Iman Kundu, Melissa Kelly, Ryan Soles","doi":"10.1093/ajcp/aqaf101","DOIUrl":"10.1093/ajcp/aqaf101","url":null,"abstract":"<p><strong>Objective: </strong>We sought to determine the extent and distribution of workforce shortages within US medical laboratories.</p><p><strong>Methods: </strong>The survey was conducted through collaboration between the American Society for Clinical Pathology's (ASCP's) Institute for Science, Technology and Policy in Washington, DC, and the Evaluation, Measurement and Assessment Department and ASCP Board of Certification in Chicago, Illinois. Data were collected using an internet survey distributed to individuals in a position to report on staffing and certifications for their laboratories.</p><p><strong>Results: </strong>Findings from the ASCP 2024 Vacancy Survey indicate that although vacancy rates have declined compared with 2022, they remain elevated relative to those observed before the COVID-19 pandemic. Retirement rates continue to rise, with 10 of the 17 laboratory departments surveyed reporting increases. Among surveyed laboratory departments, the most frequently cited concern regarding artificial intelligence was the challenge of adapting to emerging technologies. Despite this sentiment, the perceived potential of artificial intelligence to transform laboratory operations remains a major source of enthusiasm.</p><p><strong>Conclusions: </strong>Current vacancy survey data suggest continued challenges in recruitment of laboratory professionals. Qualitative analysis results show that there is an urgent need for advocacy for laboratory professionals, increased credentialing of laboratory professionals, and an increase in the number of laboratory education and training programs.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"759-777"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145184428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study. 与导管原位癌相邻的非典型导管增生的观察者间一致性和组织学分析:一项多机构研究。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf088
Ujunwa Korie, Di Ai, Peter Podany, Huina Zhang, Haiying Zhan, Mohamed Kahila, Lorraine Colon-Cartagena, Shi Wei, Hongxia Sun, Jing Du, Uma Krishnamurti, Yuanxin Liang

Objective: Atypical ductal hyperplasia (ADH) shares histologic features with low-grade ductal carcinoma in situ (DCIS). "ADH bordering on DCIS" represents a diagnostic gray zone with variable interobserver agreement, complicating clinical management.

Methods: We retrospectively analyzed 54 cases of ADH bordering on DCIS between 2010 and 2023. Each case underwent independent histologic review by multiple breast pathologists from different institutions. Histologic features, radiologic findings, clinical follow-up data, and interobserver agreement were analyzed.

Results: While pathologists showed moderate to substantial agreement on individual histologic features, agreement in distinguishing ADH from DCIS was poor (κ = 0.16). Lesion extent (47.7%) was the most frequently cited diagnostic factor, followed by nuclear features (24.9%) and duct involvement (18.5%). Among biopsy cases, those with carcinoma (DCIS or invasive) on subsequent excision (n = 22) were compared to those without (n = 16). Nuclear size more than 2-fold of background epithelial cells (P = .02), spindle-shaped nuclei (P = .006), and necrosis (P = .048) were significantly associated with carcinoma on excision. The presence of any 1 feature had 36.4% sensitivity and 72.2% specificity.

Conclusions: Breast pathologists demonstrated substantial agreement on individual histologic features but poor agreement on final diagnoses, likely due to differences in weighting histologic parameters. While lesion extent was frequently cited, it did not significantly differ between cases with and without carcinoma on excision. Instead, nuclear enlargement, necrosis, and spindle-shaped nuclei were significantly associated with carcinoma in subsequent excision. We propose that biopsy cases exhibiting a nuclear size more than 2-fold of background epithelial cells, necrosis, or spindle-shaped nuclei should be suggestive of DCIS.

目的:非典型导管增生(ADH)与低级别导管原位癌(DCIS)具有相同的组织学特征。“ADH与DCIS交界”是一个诊断的灰色地带,观察者之间的意见不一,使临床管理复杂化。方法:回顾性分析2010 ~ 2023年间54例与DCIS交界的ADH。每个病例都由来自不同机构的多名乳腺病理学家进行了独立的组织学检查。我们分析了组织学特征、影像学表现、临床随访资料和观察者间的一致性。结果:虽然病理学家在个体组织学特征上表现出中度到基本的一致,但在区分ADH和DCIS方面的一致性很差(κ = 0.16)。病变范围(47.7%)是最常被引用的诊断因素,其次是核特征(24.9%)和导管受累(18.5%)。在活检病例中,将随后切除的癌(DCIS或浸润性)患者(n = 22)与未切除的患者(n = 16)进行比较。细胞核大小大于背景上皮细胞的2倍(P =。02),梭形核(P =。006),坏死(P = .048)与切除后的癌有显著相关性。任何1个特征的敏感性为36.4%,特异性为72.2%。结论:乳腺病理学家在个体组织学特征上表现出了实质性的一致,但在最终诊断上的一致性较差,可能是由于组织学参数权重的差异。虽然经常引用病变范围,但在有癌和无癌的病例中,切除后的病变范围没有显著差异。相反,核扩大、坏死和梭形核在随后的切除中与癌显著相关。我们建议活检显示细胞核大小大于背景上皮细胞2倍、坏死或梭形核的病例应提示DCIS。
{"title":"Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study.","authors":"Ujunwa Korie, Di Ai, Peter Podany, Huina Zhang, Haiying Zhan, Mohamed Kahila, Lorraine Colon-Cartagena, Shi Wei, Hongxia Sun, Jing Du, Uma Krishnamurti, Yuanxin Liang","doi":"10.1093/ajcp/aqaf088","DOIUrl":"10.1093/ajcp/aqaf088","url":null,"abstract":"<p><strong>Objective: </strong>Atypical ductal hyperplasia (ADH) shares histologic features with low-grade ductal carcinoma in situ (DCIS). \"ADH bordering on DCIS\" represents a diagnostic gray zone with variable interobserver agreement, complicating clinical management.</p><p><strong>Methods: </strong>We retrospectively analyzed 54 cases of ADH bordering on DCIS between 2010 and 2023. Each case underwent independent histologic review by multiple breast pathologists from different institutions. Histologic features, radiologic findings, clinical follow-up data, and interobserver agreement were analyzed.</p><p><strong>Results: </strong>While pathologists showed moderate to substantial agreement on individual histologic features, agreement in distinguishing ADH from DCIS was poor (κ = 0.16). Lesion extent (47.7%) was the most frequently cited diagnostic factor, followed by nuclear features (24.9%) and duct involvement (18.5%). Among biopsy cases, those with carcinoma (DCIS or invasive) on subsequent excision (n = 22) were compared to those without (n = 16). Nuclear size more than 2-fold of background epithelial cells (P = .02), spindle-shaped nuclei (P = .006), and necrosis (P = .048) were significantly associated with carcinoma on excision. The presence of any 1 feature had 36.4% sensitivity and 72.2% specificity.</p><p><strong>Conclusions: </strong>Breast pathologists demonstrated substantial agreement on individual histologic features but poor agreement on final diagnoses, likely due to differences in weighting histologic parameters. While lesion extent was frequently cited, it did not significantly differ between cases with and without carcinoma on excision. Instead, nuclear enlargement, necrosis, and spindle-shaped nuclei were significantly associated with carcinoma in subsequent excision. We propose that biopsy cases exhibiting a nuclear size more than 2-fold of background epithelial cells, necrosis, or spindle-shaped nuclei should be suggestive of DCIS.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"704-711"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of nucleophosmin 1 immunostain in detecting leukemia cutis of acute myeloid leukemia with NPM1 mutation. 核磷蛋白1免疫染色检测NPM1突变急性髓系白血病表皮的作用。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf089
Rossana N Lazcano Segura, Valentina Nardi, Mai P Hoang

Objective: The role of NPM1 immunostaining as a surrogate marker for acute myeloid leukemia (AML) with nucleophosmin (NPM1) mutation (AML-NPM1) in leukemia cutis has not been investigated.

Methods: NPM1 immunostaining was performed using a polyclonal antibody on leukemia cutis diagnosed in 2017-2024 of 15 patients with and 15 without the NPM1 mutation. Targeted next-generation sequencing assays were performed on the initial bone marrow biopsy specimens.

Results: There were 18 skin biopsy specimens from 15 patients (11 men, 4 women, 33-90 years, median: 66 years) with AML-NPM1. Thirteen (87%) patients had multiple lesions, often on the trunk and extremities. There were 8 and 10 skin biopsies done concurrently and after the bone marrow AML diagnosis, respectively. The time interval between AML-NPM1 diagnosis and leukemia cutis was 0 to 38 months (median, 1 month). NPM1 immunostaining was positive in 18 of 18 skin biopsy specimens of patients with AML-NPM1 with a leukemic infiltrate. NPM1 immunostaining was negative in 15 of 15 leukemia cutis specimens of patients with AML who had other molecular alterations not involving NPM1. The sensitivity and specificity of NPM1 immunostaining in detecting cutaneous AML-NPM1 infiltrate are 100% and 100%, respectively.

Conclusions: Although limited in number, our study shows that NPM1 immunostaining is sensitive and specific in detecting AML-NPM1-mutated cells in skin.

目的:尚未研究NPM1免疫染色作为核磷蛋白(NPM1)突变(AML-NPM1)急性髓系白血病(AML)的替代标志物的作用。方法:采用多克隆抗体对15例NPM1突变患者和15例未突变患者2017-2024年诊断的白血病皮肤进行NPM1免疫染色。对初始骨髓活检标本进行靶向新一代测序测定。结果:15例AML-NPM1患者(男11例,女4例,33-90岁,中位66岁)18例皮肤活检标本。13例(87%)患者有多发病变,多见于躯干和四肢。骨髓AML诊断后分别行8例和10例皮肤活检。AML-NPM1诊断至皮肤白血病的时间间隔为0 ~ 38个月(中位数为1个月)。AML-NPM1伴白血病浸润患者的18例皮肤活检标本中有18例NPM1免疫染色阳性。在AML患者的15例白血病皮肤标本中,有15例存在与NPM1无关的其他分子改变,NPM1免疫染色为阴性。NPM1免疫染色检测皮肤AML-NPM1浸润的敏感性和特异性分别为100%和100%。结论:虽然数量有限,但我们的研究表明,NPM1免疫染色在检测皮肤aml -NPM1突变细胞方面具有敏感性和特异性。
{"title":"Role of nucleophosmin 1 immunostain in detecting leukemia cutis of acute myeloid leukemia with NPM1 mutation.","authors":"Rossana N Lazcano Segura, Valentina Nardi, Mai P Hoang","doi":"10.1093/ajcp/aqaf089","DOIUrl":"10.1093/ajcp/aqaf089","url":null,"abstract":"<p><strong>Objective: </strong>The role of NPM1 immunostaining as a surrogate marker for acute myeloid leukemia (AML) with nucleophosmin (NPM1) mutation (AML-NPM1) in leukemia cutis has not been investigated.</p><p><strong>Methods: </strong>NPM1 immunostaining was performed using a polyclonal antibody on leukemia cutis diagnosed in 2017-2024 of 15 patients with and 15 without the NPM1 mutation. Targeted next-generation sequencing assays were performed on the initial bone marrow biopsy specimens.</p><p><strong>Results: </strong>There were 18 skin biopsy specimens from 15 patients (11 men, 4 women, 33-90 years, median: 66 years) with AML-NPM1. Thirteen (87%) patients had multiple lesions, often on the trunk and extremities. There were 8 and 10 skin biopsies done concurrently and after the bone marrow AML diagnosis, respectively. The time interval between AML-NPM1 diagnosis and leukemia cutis was 0 to 38 months (median, 1 month). NPM1 immunostaining was positive in 18 of 18 skin biopsy specimens of patients with AML-NPM1 with a leukemic infiltrate. NPM1 immunostaining was negative in 15 of 15 leukemia cutis specimens of patients with AML who had other molecular alterations not involving NPM1. The sensitivity and specificity of NPM1 immunostaining in detecting cutaneous AML-NPM1 infiltrate are 100% and 100%, respectively.</p><p><strong>Conclusions: </strong>Although limited in number, our study shows that NPM1 immunostaining is sensitive and specific in detecting AML-NPM1-mutated cells in skin.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"712-720"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning model for automated detection of Helicobacter pylori and intestinal metaplasia on gastric biopsy digital whole slide images. 基于深度学习模型的胃活检数字整张图像中幽门螺杆菌和肠化生的自动检测。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf110
Li Y Khor, Calvin C Neo, Karthik Prathaban, Esther Choa, Wai K Quah, Eunice N Lum, Raphael Chen, Seow Y Heng, Valerie C Koh, Jia X Seow, Nagalakshmi Jegannathan, Ruoyu Shi, Shihleone Loong, Lee H Song, Anand Natarajan, Sudha Ravi, Kevin S Oh, Chee L Cheng

Objective: To develop an automated detection tool for Helicobacter pylori (HP) microorganisms (HPOrg) and intestinal metaplasia (IM) identification on gastric biopsy specimens on hematoxylin and eosin (H&E) whole-slide images (WSIs), incorporating background histopathologic features.

Methods: A total of 180 H&E gastric biopsy WSIs, archived at the Department of Anatomical Pathology, Singapore General Hospital, were used to train, validate, and test (60:20:20) a decision support tool. Eighty WSIs displayed non-HP inflammation; 100 were annotated for HP-associated gastritis, HPOrg, and IM. A 2-stage model was employed-a Vision Transformer-based model filtered artifacts after stain normalization, and then a Graph Attention Network component aggregated patch-level features, giving a prediction for each of 6 tissue sections within each WSI, with a majority vote determining the final WSI prediction.

Results: A total of 776 636 patches were used for training/validation and testing. The optimized model showed HPOrg classification (precision: 0.604, F1-score: 0.617, and top 10 micro F1-score: 0.714) and IM classification (precision: 0.905, F1-score: 0.861, and top 10 micro F1-score: 1.0). The macro average F1-score was 0.739, section-level precision was 0.981, and the F1-score was 0.945. The WSI-level precision achieved was 1.0, with a F1-score of 0.96.

Conclusions: We demonstrate a 2-stage model to detect HP and IM in gastric biopsy specimens, considering background inflammation, which more closely reflects real-world clinical diagnosis.

目的:建立一种结合背景组织病理学特征的胃活检标本苏木精和伊红(H&E)全片图像(WSIs)上幽门螺杆菌(HP)微生物(HPOrg)和肠化生(IM)的自动检测工具。方法:在新加坡总医院解剖病理学部存档的180份H&E胃活检WSIs,用于培训、验证和测试(60:20:20)决策支持工具。80例wsi表现为非hp炎症;其中100例为hp相关性胃炎、HPOrg和IM。采用了一个两阶段模型——一个基于Vision transformer的模型在染色归一化后过滤伪像,然后一个Graph Attention Network组件聚合补丁级特征,对每个WSI中的6个组织切片进行预测,并以多数投票决定最终的WSI预测。结果:共使用了776 636个贴片进行培训/验证和测试。优化后的模型采用HPOrg分类(精度:0.604,f1得分:0.617,前10名微观f1得分:0.714)和IM分类(精度:0.905,f1得分:0.861,前10名微观f1得分:1.0)。宏观平均f1得分为0.739,断面精度为0.981,f1得分为0.945。获得的wsi级精度为1.0,f1评分为0.96。结论:考虑到背景炎症,我们建立了一个两阶段模型来检测胃活检标本中的HP和IM,这更能反映现实世界的临床诊断。
{"title":"Deep learning model for automated detection of Helicobacter pylori and intestinal metaplasia on gastric biopsy digital whole slide images.","authors":"Li Y Khor, Calvin C Neo, Karthik Prathaban, Esther Choa, Wai K Quah, Eunice N Lum, Raphael Chen, Seow Y Heng, Valerie C Koh, Jia X Seow, Nagalakshmi Jegannathan, Ruoyu Shi, Shihleone Loong, Lee H Song, Anand Natarajan, Sudha Ravi, Kevin S Oh, Chee L Cheng","doi":"10.1093/ajcp/aqaf110","DOIUrl":"10.1093/ajcp/aqaf110","url":null,"abstract":"<p><strong>Objective: </strong>To develop an automated detection tool for Helicobacter pylori (HP) microorganisms (HPOrg) and intestinal metaplasia (IM) identification on gastric biopsy specimens on hematoxylin and eosin (H&E) whole-slide images (WSIs), incorporating background histopathologic features.</p><p><strong>Methods: </strong>A total of 180 H&E gastric biopsy WSIs, archived at the Department of Anatomical Pathology, Singapore General Hospital, were used to train, validate, and test (60:20:20) a decision support tool. Eighty WSIs displayed non-HP inflammation; 100 were annotated for HP-associated gastritis, HPOrg, and IM. A 2-stage model was employed-a Vision Transformer-based model filtered artifacts after stain normalization, and then a Graph Attention Network component aggregated patch-level features, giving a prediction for each of 6 tissue sections within each WSI, with a majority vote determining the final WSI prediction.</p><p><strong>Results: </strong>A total of 776 636 patches were used for training/validation and testing. The optimized model showed HPOrg classification (precision: 0.604, F1-score: 0.617, and top 10 micro F1-score: 0.714) and IM classification (precision: 0.905, F1-score: 0.861, and top 10 micro F1-score: 1.0). The macro average F1-score was 0.739, section-level precision was 0.981, and the F1-score was 0.945. The WSI-level precision achieved was 1.0, with a F1-score of 0.96.</p><p><strong>Conclusions: </strong>We demonstrate a 2-stage model to detect HP and IM in gastric biopsy specimens, considering background inflammation, which more closely reflects real-world clinical diagnosis.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"830-839"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the Genius Digital Diagnostics System on workflow and accuracy compared with the ThinPrep Imaging System for review of ThinPrep Papanicolaou tests. 与ThinPrep成像系统相比,Genius数字诊断系统对工作流程和准确性的影响,用于审查ThinPrep Papanicolaou测试。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf099
Kathleen M Murphy, Kristina Weatherhead, Carrie Chenault, Chinh Nguyen, Kari Sefcik, Sarah Harrington, Kasey Johnson, Yan Lemeshev

Objective: In this study, we compared the workflow of the Genius Digital Diagnostics System (Hologic, Inc) with our current workflow based on the ThinPrep Imaging System (Hologic, Inc) to assess potential efficiencies associated with digitalization of Papanicolaou screening.

Methods: Each step of the current workflow (glass slide movement and slide review) and the experimental workflow were documented. Substantial workflow efficiencies were associated with the reduction of glass slide movement observed with the experimental workflow of the Genius system compared with the ThinPrep system.

Results: The ThinPrep-based workflow required more than 5 hours of hands-on time at specific synchronized times throughout the day, whereas the hands-on time of the experimental Genius Digital Diagnostics System was just over an hour and allowed glass movement at flexible times. In addition to these workflow efficiencies, the Genius Digital Diagnostics System resulted in much shorter review times (70.1 seconds) than the ThinPrep Imaging system (138.0 seconds) while maintaining similar agreement to the sign-out diagnosis.

Conclusions: This study demonstrated that implementing a Genius Dx-based workflow may result in substantial efficiency gains, which can mitigate workforce shortages and improve turnaround time without compromising screening accuracy.

目的:在本研究中,我们比较了Genius数字诊断系统(Hologic, Inc)和我们目前基于ThinPrep成像系统(Hologic, Inc)的工作流程,以评估与Papanicolaou筛查数字化相关的潜在效率。方法:记录当前工作流程的每个步骤(玻片移动和玻片审查)和实验工作流程。与ThinPrep系统相比,Genius系统的实验工作流程中观察到的玻璃载玻片移动的减少与实质性的工作效率有关。结果:基于thinprep的工作流程在一天中特定的同步时间需要超过5小时的动手时间,而实验Genius数字诊断系统的动手时间仅为1小时多一点,并且允许在灵活的时间移动玻璃。除了这些工作流程效率之外,Genius数字诊断系统的审查时间(70.1秒)比ThinPrep成像系统(138.0秒)短得多,同时保持了与签出诊断相似的一致性。结论:该研究表明,实施基于Genius x的工作流程可能会带来显著的效率提高,这可以缓解劳动力短缺,在不影响筛选准确性的情况下缩短周转时间。
{"title":"Impact of the Genius Digital Diagnostics System on workflow and accuracy compared with the ThinPrep Imaging System for review of ThinPrep Papanicolaou tests.","authors":"Kathleen M Murphy, Kristina Weatherhead, Carrie Chenault, Chinh Nguyen, Kari Sefcik, Sarah Harrington, Kasey Johnson, Yan Lemeshev","doi":"10.1093/ajcp/aqaf099","DOIUrl":"10.1093/ajcp/aqaf099","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we compared the workflow of the Genius Digital Diagnostics System (Hologic, Inc) with our current workflow based on the ThinPrep Imaging System (Hologic, Inc) to assess potential efficiencies associated with digitalization of Papanicolaou screening.</p><p><strong>Methods: </strong>Each step of the current workflow (glass slide movement and slide review) and the experimental workflow were documented. Substantial workflow efficiencies were associated with the reduction of glass slide movement observed with the experimental workflow of the Genius system compared with the ThinPrep system.</p><p><strong>Results: </strong>The ThinPrep-based workflow required more than 5 hours of hands-on time at specific synchronized times throughout the day, whereas the hands-on time of the experimental Genius Digital Diagnostics System was just over an hour and allowed glass movement at flexible times. In addition to these workflow efficiencies, the Genius Digital Diagnostics System resulted in much shorter review times (70.1 seconds) than the ThinPrep Imaging system (138.0 seconds) while maintaining similar agreement to the sign-out diagnosis.</p><p><strong>Conclusions: </strong>This study demonstrated that implementing a Genius Dx-based workflow may result in substantial efficiency gains, which can mitigate workforce shortages and improve turnaround time without compromising screening accuracy.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"746-751"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12629871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic comparison of GPT models for the analysis of pathology reports in a low-resource language: A case study for Turkish. 低资源语言病理报告分析的GPT模型的系统比较:土耳其语的案例研究。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf091
Omer Faruk Dilbaz, Muhammet Nusret Ozates, Beyza Bolat, Cigdem Gunduz-Demir, Ibrahim Kulac

Objective: Large language models (LLMs) can process text for various applications, including surgical pathology reports, but studies primarily focus on English. Their performance has not been systematically studied for a low-resource language. To analyze the performance of various LLMs, 759 Turkish pathology reports from 5 different procedures were selected.

Methods: We used 10 examples from every procedure to optimize prompts for OpenAI's GPT-3.5 Turbo, GPT-4o mini, and GPT-4o. The rest was used to test generalizability.

Results: The GPT-4o model performed superior in processing Turkish reports (12%-25% over GPT-3.5 Turbo, 3%-16% over GPT-4o mini). English-translated versions of the reports have been demonstrated to enhance accuracy, especially for GPT-3.5 Turbo and GPT-4o mini. GPT4-o showed comparable results for Turkish and English. A 12% to 22% performance gap was observed between GPT-4o and GPT-3.5 Turbo for English-translated reports. Domain-related tips in prompts increased accuracy. Results of larger test sets were parallel for all models with the validation set. The GPT-4o model yielded the most accurate results, while the GPT-4o mini model demonstrated intermediate performance. The GPT-3.5 Turbo model exhibited the least accuracy.

Conclusions: To our knowledge, for the first time in the literature, we have demonstrated the performance of GPT models in Turkish surgical pathology reports, and results indicate that data extracted by GPT-4o are almost ready for direct application.

目的:大型语言模型(LLMs)可以处理各种应用的文本,包括外科病理报告,但研究主要集中在英语上。对于低资源语言,它们的表现还没有系统的研究。为了分析不同llm的表现,我们选择了来自5种不同手术的759份土耳其病理学报告。方法:对OpenAI的GPT-3.5 Turbo、gpt - 40 mini和gpt - 40进行提示优化。其余的用来测试普遍性。结果:gpt - 40模型在处理土耳其报告方面表现优越(比GPT-3.5 Turbo高12%-25%,比gpt - 40 mini高3%-16%)。报告的英文翻译版本已被证明可以提高准确性,特别是对于GPT-3.5 Turbo和gpt - 40 mini。gpt4 - 0对土耳其语和英语的测试结果相当。在英文翻译报告中,gpt - 40和GPT-3.5 Turbo之间的性能差距为12%至22%。提示中的领域相关提示提高了准确性。对于所有具有验证集的模型,较大测试集的结果是平行的。gpt - 40模型获得了最准确的结果,而gpt - 40迷你模型则表现出中等的性能。GPT-3.5 Turbo模型的准确率最低。结论:据我们所知,在文献中,我们首次在土耳其外科病理报告中展示了GPT模型的性能,结果表明GPT- 40提取的数据几乎可以直接应用。
{"title":"Systematic comparison of GPT models for the analysis of pathology reports in a low-resource language: A case study for Turkish.","authors":"Omer Faruk Dilbaz, Muhammet Nusret Ozates, Beyza Bolat, Cigdem Gunduz-Demir, Ibrahim Kulac","doi":"10.1093/ajcp/aqaf091","DOIUrl":"10.1093/ajcp/aqaf091","url":null,"abstract":"<p><strong>Objective: </strong>Large language models (LLMs) can process text for various applications, including surgical pathology reports, but studies primarily focus on English. Their performance has not been systematically studied for a low-resource language. To analyze the performance of various LLMs, 759 Turkish pathology reports from 5 different procedures were selected.</p><p><strong>Methods: </strong>We used 10 examples from every procedure to optimize prompts for OpenAI's GPT-3.5 Turbo, GPT-4o mini, and GPT-4o. The rest was used to test generalizability.</p><p><strong>Results: </strong>The GPT-4o model performed superior in processing Turkish reports (12%-25% over GPT-3.5 Turbo, 3%-16% over GPT-4o mini). English-translated versions of the reports have been demonstrated to enhance accuracy, especially for GPT-3.5 Turbo and GPT-4o mini. GPT4-o showed comparable results for Turkish and English. A 12% to 22% performance gap was observed between GPT-4o and GPT-3.5 Turbo for English-translated reports. Domain-related tips in prompts increased accuracy. Results of larger test sets were parallel for all models with the validation set. The GPT-4o model yielded the most accurate results, while the GPT-4o mini model demonstrated intermediate performance. The GPT-3.5 Turbo model exhibited the least accuracy.</p><p><strong>Conclusions: </strong>To our knowledge, for the first time in the literature, we have demonstrated the performance of GPT models in Turkish surgical pathology reports, and results indicate that data extracted by GPT-4o are almost ready for direct application.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"721-729"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12629874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underfilled tubes revisited: What blood tests can be reported on short draws? 重新审视未充血的试管:短抽时可以报告哪些血液检查?
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf109
Lawrence de Koning, Sally Ezra, Fangze Cai, Isolde Seiden-Long, Tariq Roshan, Jessica L Gifford, Albert K Y Tsui

Objective: Underfilled blood tubes (short draws) are often collected from children or those with poor venous access. In a pilot study, we investigated which tests among a large acute care panel could be reported on short draws.

Methods: Blood was drawn in BD vacutainers (short draw: 1 mL [33%-56% fill volume] vs complete draw: 1.8-3 mL [100% fill volume]) from 12 volunteers for 3 coagulation tests, 36 chemistry tests, and the complete blood count (CBC) with differential. Tests that were strong candidates for reporting did not have statistically significant biases between short and complete draws, whereas potential candidates had statistically significant biases that were small (<25% of total allowable error and less than desirable bias from biological variation). Biases that increased or decreased across concentration ranges invalidated reporting candidacy.

Results: Two coagulation tests, 14 chemistry tests, and 15 CBC components were strong candidates for reporting. There were 9 chemistry tests and 2 CBC components that were potential candidates for reporting.

Conclusions: Underfilled blood tubes, or short draws, may be valid collections for several coagulation, chemistry, and hematology tests-which may prevent additional unnecessary phlebotomy. Laboratories should perform their own studies to determine if short draws are acceptable for limited testing using their tube and instrument types.

目的:儿童或静脉通路不佳的患者常出现充血不足的情况。在一项初步研究中,我们调查了在一个大型急性护理小组中哪些测试可以在短期内报告。方法:从12名志愿者中抽取血液(短抽:1 mL[33%-56%填充体积]vs全抽:1.8-3 mL[100%填充体积]),进行3项凝血试验,36项化学试验和全血细胞计数(CBC)差异。在短抽和完全抽之间不存在统计学上显著的偏差,而潜在的候选试验存在统计学上显著的小偏差(结果:两项凝血试验、14项化学试验和15项CBC成分是报告的强候选)。有9种化学测试和2种CBC成分是报告的潜在候选者。结论:未充血的导管或短抽血可能是一些凝血、化学和血液学检查的有效收集,这可能避免额外的不必要的静脉切开术。实验室应该进行自己的研究,以确定短抽是否可以接受有限的测试,使用他们的管和仪器类型。
{"title":"Underfilled tubes revisited: What blood tests can be reported on short draws?","authors":"Lawrence de Koning, Sally Ezra, Fangze Cai, Isolde Seiden-Long, Tariq Roshan, Jessica L Gifford, Albert K Y Tsui","doi":"10.1093/ajcp/aqaf109","DOIUrl":"10.1093/ajcp/aqaf109","url":null,"abstract":"<p><strong>Objective: </strong>Underfilled blood tubes (short draws) are often collected from children or those with poor venous access. In a pilot study, we investigated which tests among a large acute care panel could be reported on short draws.</p><p><strong>Methods: </strong>Blood was drawn in BD vacutainers (short draw: 1 mL [33%-56% fill volume] vs complete draw: 1.8-3 mL [100% fill volume]) from 12 volunteers for 3 coagulation tests, 36 chemistry tests, and the complete blood count (CBC) with differential. Tests that were strong candidates for reporting did not have statistically significant biases between short and complete draws, whereas potential candidates had statistically significant biases that were small (<25% of total allowable error and less than desirable bias from biological variation). Biases that increased or decreased across concentration ranges invalidated reporting candidacy.</p><p><strong>Results: </strong>Two coagulation tests, 14 chemistry tests, and 15 CBC components were strong candidates for reporting. There were 9 chemistry tests and 2 CBC components that were potential candidates for reporting.</p><p><strong>Conclusions: </strong>Underfilled blood tubes, or short draws, may be valid collections for several coagulation, chemistry, and hematology tests-which may prevent additional unnecessary phlebotomy. Laboratories should perform their own studies to determine if short draws are acceptable for limited testing using their tube and instrument types.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"820-829"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12629873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An electronic health record-based solution to reduce the volume of CBC differentials performed on inpatients. 一种基于电子健康记录的解决方案,可减少住院患者的CBC差异量。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf106
Elizabeth Margolskee, Robert Klenk, Tracey Polsky

Objective: We sought to investigate the use of same-day, repeat complete blood cell count (CBC) with differential orders in a large pediatric institution and design an intervention to limit CBC with differential testing and, thereby, manual differential performance to once per calendar day, without placing a burden on ordering clinicians.

Methods: We created a seamless electronic health record (EHR)-based back-end workflow that reaccessions CBC with differential orders to a CBC without differential if a CBC with differential has been resulted within that calendar day. Clinicians have an opportunity to override at the time of test order entry in the EHR.

Results: Repeat CBC with differential orders originated predominantly in intensive care units (ICUs) and oncology inpatient units and accounted for 18% of all CBC with differential orders. Implementation of our EHR workflow led to an average annual reduction of 9% in CBC with differential tests and a 16% reduction in manual differentials performed. This change amounts to a combined annual cost savings (direct cost of testing plus laboratory technologist time) of approximately $45 000 and improved CBC with differential test turnaround times.

Conclusions: Our EHR-based solution resulted in a substantial and sustained decrease in CBC with differential tests and manual differential slide reviews performed in a critically ill pediatric population. This approach is a potential alternative to traditional educational and other clinician-dependent stewardship interventions that aim to improve test utilization.

目的:我们试图调查在一家大型儿科机构中使用同日重复全血细胞计数(CBC)进行差异订单的情况,并设计一种干预措施来限制CBC的差异测试,从而将人工差异表现限制在每个日历日一次,而不会给订购临床医生带来负担。方法:我们创建了一个无缝的基于电子健康记录(EHR)的后端工作流程,如果在该日历日内发现有差异的CBC,则将有差异的CBC重新加入为无差异的CBC。临床医生有机会在EHR测试订单输入时重写。结果:不同医目的重复CBC主要发生在重症监护病房(icu)和肿瘤科住院病房,占所有不同医目CBC的18%。我们的EHR工作流程的实施使CBC的差异测试平均每年减少9%,手动差异测试减少16%。这一变化总共节省了大约45000美元的年度成本(测试的直接成本加上实验室技术人员的时间),并改善了CBC与不同的测试周转时间。结论:我们基于ehr的解决方案在危重儿科人群中进行了鉴别测试和手动鉴别载玻片检查,导致CBC大幅持续下降。这种方法是一种潜在的替代传统的教育和其他临床医生依赖的管理干预措施,旨在提高测试的利用率。
{"title":"An electronic health record-based solution to reduce the volume of CBC differentials performed on inpatients.","authors":"Elizabeth Margolskee, Robert Klenk, Tracey Polsky","doi":"10.1093/ajcp/aqaf106","DOIUrl":"10.1093/ajcp/aqaf106","url":null,"abstract":"<p><strong>Objective: </strong>We sought to investigate the use of same-day, repeat complete blood cell count (CBC) with differential orders in a large pediatric institution and design an intervention to limit CBC with differential testing and, thereby, manual differential performance to once per calendar day, without placing a burden on ordering clinicians.</p><p><strong>Methods: </strong>We created a seamless electronic health record (EHR)-based back-end workflow that reaccessions CBC with differential orders to a CBC without differential if a CBC with differential has been resulted within that calendar day. Clinicians have an opportunity to override at the time of test order entry in the EHR.</p><p><strong>Results: </strong>Repeat CBC with differential orders originated predominantly in intensive care units (ICUs) and oncology inpatient units and accounted for 18% of all CBC with differential orders. Implementation of our EHR workflow led to an average annual reduction of 9% in CBC with differential tests and a 16% reduction in manual differentials performed. This change amounts to a combined annual cost savings (direct cost of testing plus laboratory technologist time) of approximately $45 000 and improved CBC with differential test turnaround times.</p><p><strong>Conclusions: </strong>Our EHR-based solution resulted in a substantial and sustained decrease in CBC with differential tests and manual differential slide reviews performed in a critically ill pediatric population. This approach is a potential alternative to traditional educational and other clinician-dependent stewardship interventions that aim to improve test utilization.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"806-812"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the process reproducibility of meta-analyses published in the top 20 pathology journals: A cross-sectional study. 评估前20名病理学期刊上发表的荟萃分析的过程可重复性:一项横断面研究。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf103
Griffin Hughes, Cameron Barton, Matt Vassar

Objective: The objective of this study is to investigate the rigor of reporting and the potential for process reproducibility of meta-analyses published within top pathology journals.

Methods: This cross-sectional, meta-research study assessed eligible systematic reviews with meta-analysis indexed in MEDLINE through PubMed. We included those studies that were published within the top 20 pathology journals (h-5 index) from inception to March 21, 2024. We extracted proper reporting variables across 4 key quantitative synthesis domains: (1) primary study eligibility, (2) search strategy, (3) screening and extraction methods, and (4) quantitative synthesis approach.

Results: We found 282 studies eligible for masked duplicate data extraction. Less than half of studies (40.8% ± 2.9%) reported whether unpublished literature was eligible for inclusion, while less than 20% reported the date of their database search (18.8% ± 2.3%). Similarly, less than 20% reported a full, reproducible search strategy (19.1% ± 2.3%). Not all studies reported primary study effects (92.9% ± 1.5%). The reported use or mention of a relevant synthesis reporting guideline was associated with significant improvement in reporting of search factors (P < .001) and screening factors (P < .001). Nine meta-analyses (9 of 282; 3.2%) were deemed potentially process-reproducible.

Conclusions: Fewer than 10 meta-analyses from top pathology journals were potentially process-reproducible without reasonable effort. Most individual summary estimates were reproducible due to the presence of forest plots. Nevertheless, reproducibility factors related to search strategies are the single largest hindrance to reproducible meta-analyses published within our sample.

目的:本研究的目的是调查发表在顶级病理学期刊上的荟萃分析报告的严谨性和过程可重复性的潜力。方法:这项横断面的meta研究评估了通过PubMed在MEDLINE索引的meta分析的合格系统综述。我们纳入了从创刊到2024年3月21日在病理学期刊(h-5指数)排名前20位的研究。我们在4个关键的定量合成领域中提取了适当的报告变量:(1)主要研究资格,(2)搜索策略,(3)筛选和提取方法,以及(4)定量合成方法。结果:我们发现有282项研究符合屏蔽重复数据提取的条件。不到一半的研究(40.8%±2.9%)报告了未发表文献是否符合纳入条件,不到20%的研究报告了数据库检索的日期(18.8%±2.3%)。同样,不到20%的人报告了一个完整的、可重复的搜索策略(19.1%±2.3%)。并非所有研究都报告了主要研究效应(92.9%±1.5%)。报告中使用或提及相关的综合报告指南与搜索因子报告的显著改善相关(P结论:来自顶级病理学期刊的荟萃分析中,只有不到10个在没有合理努力的情况下具有潜在的过程可重复性。由于森林样地的存在,大多数个体的汇总估计值是可重复的。然而,与搜索策略相关的可重复性因素是在我们的样本中发表可重复性荟萃分析的最大障碍。
{"title":"Assessing the process reproducibility of meta-analyses published in the top 20 pathology journals: A cross-sectional study.","authors":"Griffin Hughes, Cameron Barton, Matt Vassar","doi":"10.1093/ajcp/aqaf103","DOIUrl":"10.1093/ajcp/aqaf103","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to investigate the rigor of reporting and the potential for process reproducibility of meta-analyses published within top pathology journals.</p><p><strong>Methods: </strong>This cross-sectional, meta-research study assessed eligible systematic reviews with meta-analysis indexed in MEDLINE through PubMed. We included those studies that were published within the top 20 pathology journals (h-5 index) from inception to March 21, 2024. We extracted proper reporting variables across 4 key quantitative synthesis domains: (1) primary study eligibility, (2) search strategy, (3) screening and extraction methods, and (4) quantitative synthesis approach.</p><p><strong>Results: </strong>We found 282 studies eligible for masked duplicate data extraction. Less than half of studies (40.8% ± 2.9%) reported whether unpublished literature was eligible for inclusion, while less than 20% reported the date of their database search (18.8% ± 2.3%). Similarly, less than 20% reported a full, reproducible search strategy (19.1% ± 2.3%). Not all studies reported primary study effects (92.9% ± 1.5%). The reported use or mention of a relevant synthesis reporting guideline was associated with significant improvement in reporting of search factors (P < .001) and screening factors (P < .001). Nine meta-analyses (9 of 282; 3.2%) were deemed potentially process-reproducible.</p><p><strong>Conclusions: </strong>Fewer than 10 meta-analyses from top pathology journals were potentially process-reproducible without reasonable effort. Most individual summary estimates were reproducible due to the presence of forest plots. Nevertheless, reproducibility factors related to search strategies are the single largest hindrance to reproducible meta-analyses published within our sample.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"785-792"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145231344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The first report of biliary NUT carcinoma with a fatal outcome. 胆道NUT癌致死性的首个报告。
IF 1.9 4区 医学 Q2 PATHOLOGY Pub Date : 2025-11-19 DOI: 10.1093/ajcp/aqaf104
Aryeh Stock, Chao Fan, Sara Lewis, Myron Schwartz, Swan Thung

Objective: NUT carcinoma (NC) is a rare epithelial malignancy caused by a rearrangement of the nuclear protein in testis gene (NUTM1), with fewer than 200 cases reported worldwide to date. The majority of cases have occurred in young patients (ie, ≤25 years of age), most commonly in the thoracic and head and neck regions. This case marks the first documented occurrence of NC in the hepatobiliary system.

Methods: A 35-year-old woman presented with abdominal pain radiating to the back that has persisted for 2 weeks. Liver tests revealed obstructive jaundice. An abdominal magnetic resonance imaging scan demonstrated diffuse intrahepatic bile duct dilatation resulting from a stricture at the biliary confluence. Subsequent endoscopic retrograde cholangiopancreatography biopsy confirmed an invasive, poorly differentiated carcinoma, and a stent was placed in the left hepatic duct. Following right portal vein embolization, the patient underwent an extended right hepatectomy.

Results: Pathology revealed a firm 2.5-cm gray-white mass at the hepatic duct bifurcation. The initial diagnosis was a biliary carcinoma characterized by mass formation and a periductal infiltrating pattern. The tumor exhibited distinctive features, such as nested architecture, open vesicular chromatin, focal squamous differentiation, and perineural vascular invasion. Positive immunohistochemistry for CK7, CK19, P40, P63, and NUT protein and identification on DNA sequencing of a BRD3::NUTM1 fusion led to a final diagnosis of NC. Despite adjuvant chemotherapy, the patient succumbed to recurrent disease 18 months after surgery.

Conclusions: This case highlights the importance of recognizing NC in atypical locations and emphasizes the need for a thorough investigation in young patients with malignancies that display squamous differentiation. This report expands our understanding of biliary NC and underscores the challenges associated with its diagnosis and management.

目的:NUT癌(NC)是一种罕见的由睾丸核蛋白基因(NUTM1)重排引起的上皮恶性肿瘤,迄今为止全球报道的病例不足200例。大多数病例发生在年轻患者(即≤25岁),最常见于胸部和头颈部。该病例标志着第一次在肝胆系统发生NC。方法:一名35岁的女性,腹痛放射到背部,持续了2周。肝脏检查显示梗阻性黄疸腹部磁共振成像扫描显示肝内胆管弥漫性扩张,由胆道汇合处狭窄引起。随后内镜逆行胰胆管造影活检证实为浸润性低分化癌,并在左肝管置入支架。在右门静脉栓塞后,患者接受了扩大的右肝切除术。结果:病理示肝管分叉处一2.5 cm灰白色硬块。最初的诊断是胆道癌,以肿块形成和导管周围浸润为特征。肿瘤表现出独特的特征,如巢状结构、开放的囊泡染色质、局灶鳞状分化和神经周围血管浸润。CK7、CK19、P40、P63和NUT蛋白的免疫组化阳性,以及BRD3::NUTM1融合的DNA测序鉴定,最终诊断为NC。尽管进行了辅助化疗,但患者在手术后18个月因复发而死亡。结论:该病例强调了在非典型部位识别NC的重要性,并强调了对表现为鳞状分化的年轻恶性肿瘤患者进行彻底调查的必要性。本报告扩展了我们对胆道NC的理解,并强调了与其诊断和管理相关的挑战。
{"title":"The first report of biliary NUT carcinoma with a fatal outcome.","authors":"Aryeh Stock, Chao Fan, Sara Lewis, Myron Schwartz, Swan Thung","doi":"10.1093/ajcp/aqaf104","DOIUrl":"10.1093/ajcp/aqaf104","url":null,"abstract":"<p><strong>Objective: </strong>NUT carcinoma (NC) is a rare epithelial malignancy caused by a rearrangement of the nuclear protein in testis gene (NUTM1), with fewer than 200 cases reported worldwide to date. The majority of cases have occurred in young patients (ie, ≤25 years of age), most commonly in the thoracic and head and neck regions. This case marks the first documented occurrence of NC in the hepatobiliary system.</p><p><strong>Methods: </strong>A 35-year-old woman presented with abdominal pain radiating to the back that has persisted for 2 weeks. Liver tests revealed obstructive jaundice. An abdominal magnetic resonance imaging scan demonstrated diffuse intrahepatic bile duct dilatation resulting from a stricture at the biliary confluence. Subsequent endoscopic retrograde cholangiopancreatography biopsy confirmed an invasive, poorly differentiated carcinoma, and a stent was placed in the left hepatic duct. Following right portal vein embolization, the patient underwent an extended right hepatectomy.</p><p><strong>Results: </strong>Pathology revealed a firm 2.5-cm gray-white mass at the hepatic duct bifurcation. The initial diagnosis was a biliary carcinoma characterized by mass formation and a periductal infiltrating pattern. The tumor exhibited distinctive features, such as nested architecture, open vesicular chromatin, focal squamous differentiation, and perineural vascular invasion. Positive immunohistochemistry for CK7, CK19, P40, P63, and NUT protein and identification on DNA sequencing of a BRD3::NUTM1 fusion led to a final diagnosis of NC. Despite adjuvant chemotherapy, the patient succumbed to recurrent disease 18 months after surgery.</p><p><strong>Conclusions: </strong>This case highlights the importance of recognizing NC in atypical locations and emphasizes the need for a thorough investigation in young patients with malignancies that display squamous differentiation. This report expands our understanding of biliary NC and underscores the challenges associated with its diagnosis and management.</p>","PeriodicalId":7506,"journal":{"name":"American journal of clinical pathology","volume":" ","pages":"793-799"},"PeriodicalIF":1.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of clinical pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1